Kieuhoa T. Vo

Also affiliated with UCSF Benioff Children's Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.”.

Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10526

N/A

0DataRank · unranked

9 citations

Jennifer Michlitsch, Avanthi Tayi Shah, Joel M. Reid, Sarah A. Burhow, Eloise M. Graham +7 more

A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0987

N/A

0DataRank · unranked

41 citations

Tej D. Azad, Marcus R. Breese, Jacob J. Chabon, Emily G. Hamilton, Krystal Straessler +18 more

Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

Pediatric Blood & Cancer(2022)10.1002/pbc.29616

N/A

0DataRank · unranked

14 citations

Steven G. DuBois, John Neuhaus, Steve Braunstein, Brent R. Weil, Arlene Naranjo +4 more

Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3009

N/A

0DataRank · unranked

16 citations

Amit J. Sabnis, Paul M. Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies: A narrow therapeutic window of promise and peril

(2022)10.22541/au.167143348.81952940/v1

N/A

0DataRank · unranked

1 citations

Kathryn Aaronson, Anurag K. Agrawal, Benjamin S. Braun, Carla Golden, Benjamin J. Huang +6 more

Clinical and biologic predictors of response to MIBG therapy: A report from the new approaches to neuroblastoma therapy (NANT) consortium.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e22003

N/A

0DataRank · unranked

0 citations

Katherine K. Matthay, Susan Groshen, Yueh‐Yun Chi, Meaghan Granger, Julie R. Park +3 more

Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies

Pediatric Blood & Cancer(2023)10.1002/pbc.30335

N/A

0DataRank · unranked

13 citations

Kathryn Aaronson, Anurag K. Agrawal, Benjamin S. Braun, Carla Golden, Benjamin J. Huang +6 more

Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131I‐MIBG in patients with relapsed/refractory neuroblastoma

Pediatric Blood & Cancer(2023)10.1002/pbc.30743

N/A

0DataRank · unranked

5 citations

Ajami Gikandi, Bruce Pawel, Daniel Martínez, Meaghan Granger, Araz Marachelian +6 more

Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110384

N/A

0DataRank · unranked

4 citations

S. Shaaban, Jie Jane Chen, Rochelle Bagatell, Benjamin Lerman, Paul J. Catalano +20 more